U.S. Says No Proposal Made On Biologics At Singapore Leg Of TPP Talks; Japan Set To Join Fray
This article was originally published in PharmAsia News
Executive Summary
The 16th round of talks to build a Trans-Pacific Partnership trade deal among 11, and possibly at least one more nation, conclude in Singapore with the issue of data exclusivity for biologics in limbo.